Junli Mou

机构：The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing Medical University · ORCID：0000-0002-9387-4895

发表论文 33 篇 · 总被引 314 次 · h-index 8

代表论文

• Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity (2024 · Cell stem cell · 被引 68)
• Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity (2023 · 癌症：英文版 · 被引 13)
• Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells (2023 · Human Gene Therapy · 被引 9)
• 2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cell lymphoma 2 signal pathway (2023 · Cytotherapy · 被引 9)
• Identifying ADGRG1 as a specific marker for tumor-reactive T cells in acute myeloid leukemia (2024 · Experimental Hematology and Oncology · 被引 8)
• Targeting Fatty Acid Metabolism Abrogates the Differentiation Blockade in Preleukemic Cells (2024 · Cancer Research · 被引 7)